Home > Share Market > Stocks > Balaxi pharmaceuticals > Financial Statements> BALAXI Profit & Loss

Balaxi Pharmaceuticals Ltd Financial Statements

Profit & Loss Statement of Balaxi Pharmaceuticals Ltd

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 -
Revenue 231 45.60 13.60 --
yoy growth (%) 407 236 -- --
Raw materials (172) (34) (10) --
As % of sales 74.40 73.60 75.30 --
Employee costs (8.50) (2.10) (0.90) --
As % of sales 3.66 4.60 6.63 --
Other costs (8.30) (3.90) (0.90) --
As % of sales 3.59 8.52 6.63 --
Operating profit 42.40 6.07 1.56 --
OPM 18.30 13.30 11.40 --
Depreciation (0.30) -- -- --
Interest expense -- -- -- --
Other income 2.23 2.81 0.89 --
Profit before tax 44.30 8.87 2.44 --
Taxes (6.20) (2.80) (0.50) --
Tax rate (14) (31) (19) --
Minorities and other -- -- -- --
Adj. profit 38.10 6.10 1.97 --
Exceptional items -- -- -- --
Net profit 38.10 6.10 1.97 --
yoy growth (%) 525 210 -- --
NPM 16.50 13.40 14.50 --

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000